Make your live is better

Make your live is better.

Your Fammily is Your live

Your Fammily is Your live.

Care your future

Be healty .

This is default featured post 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

This is default featured post 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.

Monday, May 31, 2010

A Guide to medical transcription outsourcing

What are the factors that should guide an outsourcing decision?

There are many factors that guide the medical transcription outsourcing decision, increasing profits by reducing costs being one of the main factors. That apart there are a few other factors that make the medical transcription outsourcing decision making process easier and faster. Listed here are few of the important factors:

Skill level of the medical transcriptionists: Quality of medical transcription is a function that totally depends on the skill set of the medical transcriptionists. While outsourcing it is important to assess the medical transcription service provider on the training methods used to train their workforce. Well-trained medical transcriptionists would mean that the accuracy of the transcripts would be very high.

TransDyne recruits the best candidates through a detailed screening process to ensure that the best talent is recruited. They are then provided with extensive training in all the skills required.

The training process is taken further as TransDyne believes that it takes a specialist to take care of special needs. That is why thier medical transcriptionists are trained in one or two areas of medicine so that they become Domain specialists in that area of medicine. Specialty training assures that accuracy levels are high from the very beginning.

Ensure that security measures taken by the medical transcription service provider are adequate: While outsourcing medical transcription it is imperative to choose a service provider, which understands the significance of maintaining confidentiality of patient data by taking appropriated security measures.

TransDyne ensures data security by incorporating security measures like 128-bit data encryption, multi-tiered application architecture, design level security, safeguards, firewall protected networks, sterilized e-mail servers, denial of access procedure and multi modal alerts.

TransDyne further ensures data security by ensuring that data doesn’t leave it’s premises physically. To ensure secure medical transcription all the transcription is done in TransDyne’s premises and the premises are secured through appropriate security measures. TransDyne meets all the HIPAA and HITECH regulations.

Check on the methods and guidelines used for assuring accuracy level: Accuracy or quality of the documents transcribed is of utmost importance given the criticality of the data. Assessing the medical transcription service provider on the basis of methods used for producing accurate transcripts will show their commitment to quality.

TransDyne offers quality transcription with accuracy of 99% or above. TransDyne ensures quality by adopting a four level quality check of medical transcriptionist, language proofreader, unit in charge and finally by the quality assurance team which tries to minimize errors before returning the finished reports.

Check for success stories: Nothing gives more comfort to a healthcare facility than knowing that others have benefited by services offered by the medical transcription service provider that they have chosen for their outsourcing needs.

TransDyne’s website has the testimonials of the success stories of some of the healthcare leaders on the website.

Look at the contract closely: While outsourcing the medical transcription needs of a healthcare facility one of the main risks is that the medical transcription service provider may get the work executed by hiring sub-contractors. This will not only compromise the data confidentiality but also affect the quality and turnaround time of the finished transcripts. Provisions have to be added to the contract after careful study to ensure that this does not happen.

TransDyne believes that they can service their clients in the best possible way by having the work executed by their own team of trained and trusted transcriptionists. TransDyne believes that sub-contractors would consider the work as just another job and not apply stringent quality measures to ensure accuracy. Therefore TransDyne takes great pride in executing all the medical transcription work through their in house team of specialist medical transcriptionists.

Check whether current dictation modes can be used: Choosing a medical transcription service provider which does not necessitate change in dictation modes would mean a huge saving of time for doctors and also save on further capital investment for new dictation devices.

TransDyne believes that the doctors’ time is precious and that is why we offer flexible modes of dictation. Doctors can dictate using their existing dictation devices, use digital reorders or even use mobile phones to record their dictation into our toll free numbers.

Whether it is accuracy of transcripts or maintaining turnaround time or security of data or fair pricing methods or the technology used, one can be assured that TransDyne satisfies their clients on all counts.

To avail outsourced medical transcription services from TransDyne, click here

Sunday, May 30, 2010

Did EPIC CEO Judy Faulkner of Epic declare that �healthcare IT usability would be part of certification over her dead body?'

At the HisTALK blog 5/31/10 update, a site with thousands of readers involved in all aspects of health IT, the following anonymous (at this point) report appeared:

From Tabula Rosa: �Re: EMR usability. At one of the ONC Policy Committee meetings, [founder and CEO] Judy Faulkner of Epic supposedly declared that �usability would be part of certification over her dead body.� I wonder if she has similar sentiments about making software accessible to people with disabilities?� Unverified. This inspired my new poll question � keep reading below.

Epic Systems Corporation is one of the largest health IT vendors in the U.S.

If this report is true, it would have very, very serious implications towards the healthcare IT industry's attitudes about the usability - and ultimately the safety - of its products.

The essential nature of usability and the relationship to safety is not an issue for debate - period. It was settled long ago in relation not only to IT, but also to devices and machinery that use IT. For instance, see the mid 1980's wisdom written for the U.S. Air Force on user interfaces at my eight part series on mission hostile health IT user experiences at http://tinyurl.com/hostileuserexper. Microsoft and other responsible IT vendors spend billions on usability research.

I think it incumbent of the U.S. Office of the National Coordinator for Health IT, and its leader Dr. David Blumenthal, to confirm or deny that such a statement was made, on or off-record, at an ONC policy committee meeting, and if it was made, its exact context.

If it was made, it would raise the following questions:

  • Would its utterer be saying this out of concern that their products have usability deficiencies that competitors do not, and that are not correctable in a short time frame?
  • How much concern would such a statement indicate for the complex jobs of physicians, nurses and other clinicians whose safe conduct of their medical obligations depends on health IT?
  • How much concern would such a statement imply towards the injured and dead bodies of patients affected by health IT of deficient usability?
  • Since the CEO sets the tone for their company and has the ultimate responsibility for its conduct (and its Board of Directors as well), would such a statement reflect willful negligence and perhaps criminal conduct?

The last question is pertinent, for if, say, the CEO of Boeing were to relate that "usability of the control systems of its aircraft would be an FAA certification requirement over his or her dead body", or the CEO of oil drilling companies said same about their instrumentation that helps avoid underwater blowouts, I believe it would rise to the level of criminally negligent conduct.

This is all the more pertinent to me, as my mother was just seriously injured by a medication error that appears to have started with the med list in an EMR.

I am seriously wondering, in fact, if the average hospital has the gravitas and political and technologic maturity to truly implement health IT so that the technology is uniformly beneficial, instead of spontaneously harmful, to meet the needs of the grandiose plans for national health IT.

The lack of seriousness, petty political fights, and technological dyscompetence and incompetence I have noted in my 20 years in this field do not seem surmountable in any time frame I consider "soon."

Here seems to be the health IT industry and hospital MIS department view of healthcare IT, as some sort of game to be played for profit, power and political advantage:




-- SS

Friday, May 28, 2010

Medical transcription: What are the methods of quality assessment?

Quality is an important criterion in any decision making process. Assessing quality becomes even more important when it comes to availing service as critical as medical transcription. Medical transcription is the process of converting audio records of a patient- healthcare professional encounter into a text format.


This accuracy/quality of medical transcription critical as this forms the basis of:

  • Permanent patient history
  • Present and future treatment plan and basis for monitoring progress of the patient
  • Referrals/tests/procedure
  • Statutory requirements
  • Evidence in case of disputes/litigation
  • Accounts receivable processing
It is important that records that play such an essential role be of the highest accuracy/quality possible. While making the decision to outsource medical transcription needs it is vital to ensure that the medical transcription service provider has HPI guidelines in place for assessment of quality.

What are HPI guidelines?
The concept of Quality Assessment (QA) began in 1990 when a format was developed by Judy Hinickle to assess quality of transcription. This was followed by presentations made to thousands of transcription supervisors and educators around the country by Health Professional Institute (HPI), American Association for Medical Transcription (AAMT), American Health Information Management Association (AHIMA), and Medical Transcription Industry Association (MTIA).

Health Professions Institute then adapted and promoted this for its standard-setting SUM program for medical transcription. This QA method is the basis of most programs and is of most thorough and effective nature, embracing true Continuous Quality Improvement concepts.

TransDyne executes medical transcription using quality guidelines by HPI

What do HPI guidelines consist of?
HPI guidelines consist of quality check parameters and computing system for quality satisfaction and highest accuracy levels. HPI guidelines are categorized as follows:

Error 1. Medical Word misuse-Point 1.00
This is considered one of the most serious errors as it can affect every aspect of treatment administered to the patient. Even billing information is affected by this error. Guesswork or making up of words when dictation is not understood is also included in this error category.

Error 2. Omission- Point 1.00
This is also considered an equally serious type of error as it reflects on the ability and professionalism of the medical transcriptionist.

Error 3. Medical word misspelling- Point 0.75
This is the incorrect spelling of medical terminology.

Error 4. English word misspelling or Misuse -Point 0.75
This includes misspelling of English words nouns, verbs, qualifying adverbs etc, which could have a serious consequence.

Error 5. Inappropriate blanks- Point 0.75
These refer to blanks that are left unfilled, and those, which could be filled up by extensive research by the medical transcriptionist.

Error 6. Grammar errors- Point 0.5
Grammar errors include incorrect use of medical abbreviations, misuse of words, misuse of parts of speech, misuse of subject-verb, singular/plural misuse, etc.

Error 7. Punctuation errors- Point 0.5
Include errors with regard to punctuation like coma, colon, semi colon etc that change the meaning of the sentence if misused.

Error 8. Typographical errors- Point 0.25
Minor grammar, punctuation or capitalization errors.

Error 9. Formatting errors- Point 0.25
This error refers to the prevailing departmental/physician guidelines for placement of certain information within the document. E.g. Headers, Footers, templates as defined by the client.

Having these quality guidelines in place ensures that everybody in the TransDyne team is guided by the same principles. TransDyne offers quality medical transcription with accuracy of 99% or above. TransDyne ensures quality by adopting a four level quality check of medical transcriptionist, language proofreader, unit in charge and finally by the quality assurance team which tries to minimize errors before returning the finished reports.

To avail medical transcription services from TransDyne, click here.

Cool Technology of the Week

Every Memorial Day, I plant my summer vegetable garden with those species that do not tolerate cold - eggplant, cucumbers, corn, and peppers. I clear out the spring planting beds that were filled with numerous kinds of lettuce, turn my compost pile, and use fresh compost to amend the soil before planting.

In the Spring, I start making compost by using greens (cut grass, weeds, trimmings) and a few browns (leaves, twigs, kitchen trimmings). I add a bit of baking soda to reduce the acid content of the mix, add compost starter and moisten the mixture to the consistency of a wet sponge - not too wet, not too dry. Everything goes into my rotating compost bin.

Thus, as Memorial Day approaches I have compost on my mind, which leads to the Cool Technology of the Week - Composting Toilets.

I'm a big fan of green technologies and living off grid, which I hope to do someday. Here's how composting toilets work.

Composting is a natural process through which organic material is decomposed and used to produce a valuable soil conditioner. In a composting toilet, water is not used at all, and human waste and other organic materials are deposited into a chamber where aerobic bacteria decompose solid portions. The liquid portion (the water content of urine, feces and added organic matter) is left to evaporate through a specially designed ventilation system.

The digestion chambers fill up over time. Once full, the chamber is left to compost over a period of weeks. During this time a second chamber is used. Finished compost is rendered sterile by the heat of the composting process and can be safely removed.

Here's detailed overview from the EPA.

Waterless, green, natural composting toilets - that's cool.

Food Allergy Carnival

Looking for some great information from those active and involved in food allergy on the web? Check out the latest addition of the Food Allergy Blog Carnival. From recipes to advice to tips and ideas, you'll find it all at the latest carnival!

Thursday, May 27, 2010

Medical transcription: A necessity or luxury?

To assess whether medical transcription is a necessity or luxury one needs to look at the history of medical transcription and the role it plays in the provision of quality care and the profitability of a healthcare facility.

Evolution of medical transcription: Medical transcription is process of creating records of patient-healthcare professional encounter. Creation of records of the patient encounter has been around for a long time. Over time medical transcription has evolved from its’ early stages due to the advance of technology and the Internet. The various stages of evolution that medical transcription has gone through are as follows:

  • Hand written notes

  • Dictation-shorthand-typing on the manual typewriter

  • Dictation- recording on tapes- transcribing on manual/electronic typewriter.

  • Uploading dictation on the computer system, downloading, transcribing and uploading finished files and then transmission back to the healthcare professional through the use of Internet.
Role of medical transcription: Medical transcription has always played a behind the scene role in the form of an essential support to the process of healthcare. Medical transcription plays an important role in the following:


  • Recording the patient-healthcare professional encounter

  • Referrals/ tests

  • Statutory requirement

  • Insurance re-imbursement

  • Evidence in case of litigation

  • As part of patient medical history.
One can see that medical transcription plays an important role in the core business of a healthcare facility and its’ profitability. It would be considered a necessary service rather than a luxury.

How can this necessary function of medical transcription be made economical and efficient?

Medical transcription can be made economical and efficient by outsourcing to a professionally managed company, which needs to be evaluated on the following:

Quality/accuracy: Quality of the transcribed document refers to the percentage of accuracy in the transcribed document viz. a viz. the audio files. Accuracy level assured by the medical transcription service provider should be as close to 100% as possible

Turnaround time: Turnaround time refers to the period between uploading the audio file to the time when the finished record is made available to the healthcare professional. A turnaround time of 24 hours with quicker turnaround time options for STAT reports would be considered reasonable.

Data security: Security of confidential patient data is an important consideration. This becomes even more critical when the data is transmitted back and forth. Any prospective medical transcription service provider needs to be critically evaluated in terms of the measures taken by them to ensure security of data.

Price: Cost savings per line of transcription is perhaps one of most important considerations for outsourcing medical transcription needs. The pricing provided by the medical transcription service provider needs to be reasonable and the terms of pricing should be easy to understand.

Volume flexibility: It is not possible to predict the volume of patient inflow. Therefore it is not possible to predict the volume of medical transcription work required. A medical transcription service provider needs to be evaluated on the basis of their ability to cope up with varying volumes and factors like weekend and holiday transcription requirements.

Tchnology with maximum benefits: Technology plays an important part in the medical transcription process. It can make the process simpler, quicker and safer by providing easy methods of capturing dictation, uploading files, downloading completed records and even for archiving of patient records. Tracing the information required can be made easier through the use of technology. The medical transcription service provider should be evaluated on the use of technology in the medical transcription process.

Billing methods: The billing method used by the medical transcription service provider can have a direct impact on the profitability of the healthcare facility. The billing method needs to explained at the beginning of the process. The billing method should be evaluated to ensure that it is, verifiable, definable, measurable, consistent and fair & honest.

Success stories: Success stories or testimonials of satisfied customers can give the added comfort to the decision making process.

TransDyne, a leader in the outsourced medical transcription industry offers medical transcription services with the following benefits:

  • TransDyne offers medical transcription with an accuracy of above 99%

  • TransDyne assures a turnaround time of 24 hours with an option of 4-12 hours for STAT reports.

  • TransDyne ensures security of data by securing technology, processes and people.

  • TransDyne offers a reasonable and fair price by charging 10 cents per line, which is calculated by using the character line pricing method.

  • TransDyne maintains a large, well-trained team of medical transcriptionists, which enables them to cope with varying volumes

  • TransDyne offers medical transcription services by using the latest technology that is advanced and easy to use.

  • TransDyne uses the character line billing method that is verifiable, definable, measurable, consistent and fair & honest

  • TransDyne has the testimonials of their success stories available for viewing on their website.
To avail medical transcription services from TransDyne, click here

A "Pump and Dump" Stock Scheme and a University's "Incredible Gift"

Here is a new twist on how respected academic institutions have gained from less than respectable donors.  As reported by the Palm Beach (FL) Post,
John David Mazzuto and a colleague stole more than $60 million from his former company and its investors, New York prosecutors said Tuesday afternoon.

... the Manhattan District Attorney said today that, while he was in bankruptcy from 2002 to 2009, he siphoned more than $15 million from Industrial Enterprises, and used the money to support 'a lavish lifestyle using millions of company dollars for homes, travel, and personal expenses.'

They included Mazzuto's 7,715-square foot house at 11503 Green Bayberry Drive. Palm Beach County records show a corporation managed by him bought it for $2.6 million in 2007. No mortgage was recorded, suggesting the company bought it outright.

New York prosecutors said Mazzuto also bought a $3 million home in the exclusive Long Island community of Southampton and spent more than $500,000 to fly on private jets.

Palm Beach Gardens police arrested Mazzuto Thursday and investigators from New York were in a Palm Beach County court Monday to collect him.

The New York indictment alleges Mazzuto and Cleveland, Ohio, attorney James W. Margulies, the corporation's general counsel, illegally issued millions of shares of stock and used fraud to inflate its value and deceive investors.

Mazzuto and Margulies are charged with grand larceny, scheme to defraud, conspiracy, falsifying business records, and violations of New York State's securities fraud law.

The district attorney said the two illegally issued millions of shares to family, friends, and associates.

'The defendants stole from the corporation and legitimate investors, and engaged in a variety of fraudulent accounting and securities practices to disguise the theft and pump up the value of the stock,' the release said. It said one outside investor lost more than $20 million.

'This was the wholesale looting of a public company,' Manhattan District Attorney Cyrus R. Vance, Jr., said in a statement.

A 2007 class-action lawsuit filed by investors alleged Mazzuto had a long history of unscrupulous business practices.

It also alleged Mazzuto used more than $100,000 from insider trading to buy a Porsche for his girlfriend.

The suit said the federal Securities and Exchange Commission was investigating Industrial Enterprises for insider trading and accounting fraud during Mazzuto's tenure. The SEC has declined to comment.

Mazzuto and Industrial Enterprises, saying the accounting mistakes were unintentional, agreed in April to settle the lawsuit for $3.8 million, records show. The settlement still is awaiting the court's approval.

Industrial Enterprises has been negotiating since October for Yale to return a gift that paid for a head coach and a new all-weather baseball practice facility.

Lawsuits alleged the bequest included improperly issued stock worth $1.7 million.

The New York Times added some detail about Mezzuto's dontation to Yale:
The news release called John D. Mazzuto one of the 'greatest supporters' of the Yale University baseball team.

Mr. Mazzuto, a 1970 Yale graduate who played shortstop for the team, had donated to the baseball program about $1.5 million worth of shares in a company he owned. The university rewarded him by naming a new practice facility after him and his wife � the John and Theresa Mazzuto Field � and by adding his family name to the baseball coach�s official title: the Mazzuto Family Head Coach of Baseball.

'John has bestowed upon Yale baseball an incredible gift,' John Stuper, the baseball coach at Yale, said in the release, dated April 17, 2009. 'His support of our program has been absolutely phenomenal.'

Manhattan prosecutors said Tuesday that Mr. Mazzuto�s support of his alma mater was illegal.

Mr. Mazzuto, 61, was indicted on charges of fraudulently inflating the value of a company he owned to mislead investors into buying worthless shares. He gave shares of the company, Industrial Enterprises of America, to family and friends and to companies he controlled, and they sold them on the open market, giving some of the profits to Industrial Enterprises, prosecutors said.

Those profits made Industrial Enterprises seem as though it was in better financial health than it actually was, raising its stock�s value, prosecutors said.

'It�s a new twist on a pump-and-dump,' said Garrett A. Lynch, the assistant district attorney handling the case.

Mr. Mazzuto also gave shares of the stock to Yale, prosecutors said. The university sold its shares before their value plummeted and earned about $1.5 million, prosecutors said.

Yale officials did not know that Mr. Mazzuto was issuing stocks illegally, prosecutors said, although some of the recipients of the shares did conspire with him.

A report in the Wall Street Journal added:
Industrial Enterprises, which was based in New York at one point, sought Chapter 11 bankruptcy protection in May 2009. [a month after Yale announced the donation - Editor]

A shareholder lawsuit, filed in federal court in Manhattan in 2007, alleged the company engaged in accounting fraud by 'materially overstating' its revenue between December 2006 to November 2007. The company announced in November 2007 it had overstated revenue by millions of dollars for two quarters that year.

For the sake of fairness, I must emphasize that the allegations against Mr Mezzuto and Mr Margulies are just that. However, there ought to be considerable suspicion that something unethical was going on, at least based on the company's admission of over-stated earnings, Mr Mezzuto's provision of the gift while he apparently was in personal bankruptcy, and (at least in retrospect), the company's filing for bankruptcy weeks after the gift of its stock was announced . Thus, Yale's acceptance of the gift, and its effusive accolades to its donor at best suggest an attitude of "what, me worry."

At best, it seems that our once unimpeachable academic institutions have become so eager to raise money that the provenance of donations is no longer of interest to them.  Furthermore, it seems that anyone who provides a big donation becomes a local hero, regardless of the source of the donation.  Embracing donations arising out of questionably ethical situations implies a tacit endorsement of the means used to provide them.  Our universities ought to remember that their mission is teaching, research, and for academic medical institutions (as Yale is), patient care.  It may be true that if there is no margin, there is no mission, but if margin comes first, regardless of where it comes from, there soon will be no mission. 

The Leiter Lecture

Yesterday after the HIT Standards Committee meeting, I had the honor of delivering the 2010 Leiter Lecture at the National Library of Medicine.

My topic was the grand challenges and proposed solutions as we implement healthcare information technology in support of meaningful use with a special focus on the role of Medical Librarians and Informaticians that provide knowledge services.

Here are my slides.

My grand challenges included

1. Managing Consent for data exchange
2. Engaging Patients and resolving the National Healthcare Identifier issue
3. Accelerating use of Standards, especially vocabularies
4. Aggregating Data for population health, registries, and research
5. Providing Decision Support

Here's the streaming video.

Wednesday, May 26, 2010

Medical transcription: Why is dictation an important part in medical record creation?

Why document the patient-doctor encounter?


The documentation of the patient-doctor encounter takes place for a number of reasons, some of which are given below:

1.Records provide the medical history of the patient enabling healthcare professionals to administer the best care possible.
2.It is legally mandatory to maintain patient records.
3.Patient records provide the basis for referrals
4.Patient records are the basis on which insurance claims are made
5.Patient records provide evidence in case of malpractice suits.

Having looked at the importance of having to create medical records, now the focus is on the process of record creation. Medical transcription plays an important part in the speedy and accurate creation of medical records. The medical transcription process starts when the doctor dictates notes of the patient encounter into a recording device.

Many people have questioned the necessity of the doctors dictating notes rather than directly typing out the reports. Let us examine why dictation is necessary:

Time: Time is a scarce commodity for healthcare professionals and dictating free style could be squeezed in at any time of the day, and would not require any equipment other than their phone. Dictating notes would also take less time than actually typing as it has been proven than people can talk faster than they can type.

Expertise: The skill set of a doctor may not necessarily include typing speedily and accurately.

Speed: A medical transcriptionist could have better typing speed than a doctor. Moreover the creation of patient records would be speedier by medical transcriptionists as this is their only work; therefore the focus is totally on this.

Ease of use: It is easier for the doctor to dictate into his recording device while doing other things than to sit and type out the report.

Expense: It is cheaper for a medical transcriptionist to transcribe the report rather than the doctor waste his expertise and productivity on this task.

It is therefore better for doctors to focus on their business; providing quality healthcare and for the medical transcription service provider to focus on their business; Expert medical transcription and medical record creation.

How to improve dictation quality?

We have looked at the advantages of dictating vis-à-vis typing, now let us focus on how dictation can be improved to improve the accuracy of the transcribed reports. Given below are a few dictation tips towards accurate medical transcription:

Allot time for dictation: This will help the doctors to complete documenting the patient encounter when their memory is still fresh and capture all the details.

Allot space: Allotting a convenient space for dictation will ensure that factors like noise, distractions do not affect the quality of recording.

Collect papers: Collecting all the documents/reports required will help the doctor finish dictating accurately in less time.

Speak at a steady pace: Speaking a steady pace will ensure that words are not garbled and help the medical transcriptionist focus.

Spell difficult terms: Spelling difficult terms will ensure that the data captured is accurate.

Rewind and listen: Sometimes rewinding oneself and listening to the dictation will help clarity by highlighting the areas for improvement.

Know the equipment: Knowing the equipment being used for dictation will help the doctor to modulate his dictation, mike distance, stop/start features etc.

Relax while dictating: Treat the time spent dictating, as time for a break and this will help the doctor relax and capture all details.

Pause during interruptions: In case of any interruptions, it is better to use the pause button so that extraneous data is not captured.

Following these simple instructions will go a long way to help create accurate transcripts at an optimum turnaround time

TransDyne offers quality medical transcription at reasonable prices, done by expert medical transcriptionists with a very quick turnaround time executed through secure HIPAA and HITECH compliant channels, with very high levels of accuracy and all this with technology that is advanced but easy to use!

To avail outsourced medical transcription services from TransDyne, click here.

The May HIT Standards Committee Meeting

Today, the HIT Standards Committee held their May meeting via teleconference and discussed several important topics.

1. The National Information Exchange Model Standards and Interoperability Framework continues to make progress. 11 RFPs have been issued (I will post updates next week) and 8 will be funded shortly. Coordinating 11 different contracts which support standards harmonization, specification writing, testing etc. requires masterful orchestration. A Concept of Operations (ConOps) document will detail the processes by which all these efforts will intertwine. At the June Standards Committee meeting, we will review the ConOps document, ensuring alignment between the NIEM effort and the HIT Standards Committee work.

2. NHIN Direct continues to make substantial progress. There is much confusion in the industry about NHIN Direct. It's a project, not a product. It's a pilot, not a regulation. There is no guarantee that NHIN Direct implementation guides will be formally incorporated into the NHIN project. NHIN Direct is an agile development project with 4 development teams creating software that demonstrates SMTP/TLS, REST, SOAP, and XMPP (Jabber) protocols for transmitting data and metadata between two points. To ensure oversight, review, and comment by the HIT Standards Committee, NHIN Direct has asked for a working group to evaluate the 4 workstreams and comment on which is best to be the focus of early pilots. The HIT Standards Committee agreed to take on this task, delivering an evaluation by June 10.

3. Privacy and Security work has many threads at ONC - the HIT Standards Committee P&S Workgroup, the HIT Policy Committee P&S Workgroup, the NHIN Coordinating Committee etc. To align all the efforts, Joy Pritts, the new ONC Chief Privacy Officer, will create a Privacy and Security Tiger Team, staffed by experts from all the other workgroups. They'll work hard for 6 months to accelerate policy and technology work to support privacy and security efforts in such areas as NHIN Direct, Consent and segmentation of various parts of the healthcare record.

4, The Patient Protection and Affordable Care Act (Healthcare Reform) contains a section (1561) on healthcare IT standards for enrollment. A new multi-stakeholder workgroup will be chaired by US CTO Aneesh Chopra and California Healthcare Foundation's Sam Karp. Its initial work products are due in 120 days, covering the secure standards and protocols that facilitate enrollment of individuals in Federal and State health and human services programs.

5. The Implementation Workgroup will provide online resources to accelerate interoperability using some of the tools to be provided by the NIEM RFP contracts.

While the above work is going on, the HIT Standards Committee will continue its efforts on Vocabulary and Quality.

A great discussion. The many simultaneous ONC standards efforts have been aligned to ensure the involvement HIT Standards Committee every step of the way.


How Did the CEO Who Presided Over the Company that Paid a $1.7 Billion Fraud Settlement Become a Credible Candidate for a State Governorship?

This one fits in the "you just can't make this stuff up" category.  Let me provide a summary from the Fort Lauderdale, Florida Sun-Sentinel,
It was and still is the biggest Medicare fraud case in U.S. history and ended with the hospital giant Columbia/HCA paying a record $1.7 billion in fines, penalties and damages.

Now the man who ran the company at the time wants to be Florida's governor.


Rick Scott was co-founder and CEO of Columbia/HCA in the 1990s, when the FBI launched a massive, multi-state investigation that led to the company pleading guilty to criminal charges of overbilling the government.

Today, Scott is a Republican candidate for governor, running his campaign from an office in downtown Fort Lauderdale.

Here is the Sun-Sentinel's review of the Columbia/ HCA case from the end of the 20th century:
A Dallas lawyer whose clients included health care companies, Scott came from humble Midwestern roots � his father was a truck driver and his mother a JC Penney sales clerk. In 1987, at the age of 34, he started Columbia, investing $125,000 to buy two hospitals in El Paso, Texas.

Within a decade, he was running the largest health care company in the country with more than 340 hospitals and $20 billion in annual revenue. Columbia aggressively bought other health care companies, including the Hospital Corporation of America, and became Columbia/HCA.

The federal government began investigating in the mid 1990s with the help of whistleblowers including [Jim] Alderson and John Schilling, a Medicare reimbursement supervisor in Fort Myers.

Among the fraudulent practices uncovered: billing Medicare and Medicaid for unnecessary lab tests, creating false diagnoses to claim a higher reimbursement and charging for marketing and advertising costs that were disguised as community education. The company even billed the government for tickets to the Kentucky Derby and country club dues, according to news accounts.

The government's investigation became public in 1997 and that July, the FBI raided Columbia/HCA offices in seven states, including Florida. Days later, the board of directors announced Scott was out.

The St Petersburg Times/ Miami Herald Politifacts Florida web-site included more details about the nature of the offenses alleged:
* Columbia billed Medicare, Medicaid, the Defense Department's TRICARE health care program, and the Federal Employees' Health Benefits Program for lab tests that were not medically necessary or not ordered by physicians;
* The company attached false diagnosis codes to patient records in order to increase reimbursement to the hospitals;
* The company illegally claimed non-reimbursable marketing and advertising costs as community education;
* Columbia billed the government for home health care visits for patients who did not qualify to receive them.


It also documented the guilty pleas resulting from the charges:
Southern District of Florida (Miami) -- Columbia Homecare Group Inc., a subsidiary of Columbia, will plead guilty to one count of conspiracy to defraud the U.S. and to violate the Medicare Anti-kickback Statute involving its fraudulent business in the purchase and operation of home health agencies and fraudulent billing of Medicare for management and personnel costs. The criminal fine is $3.36 million;

Northern District of Georgia (Atlanta) -- Columbia Homecare Inc. will plead guilty to one count of violating the Medicare Anti-kickback Statute related to purchase of home health agencies. The criminal fine is $3.36 million;

Department of Justice Criminal Fraud Section -- Another subsidiary, Columbia Management Companies Inc., will plead guilty to one count of conspiracy to defraud the U.S. and to make and use false writings and documents in connection with its fraudulent 'upcoding' of bills to Medicare for patients diagnosed with certain types of pneumonia. The criminal fine is $27.5 million. This investigation was based in Nashville, Tennessee;

Middle District of Florida (Tampa) -- Columbia Homecare Group will plead guilty to one count of conspiring to defraud the U.S. and one count of conspiracy to violate the Medicare Anti-kickback Statute in connection with the purchase and operation of home health agencies. The criminal fine is $8.4 million. Also, Columbia Management Companies will plead guilty to eight counts of making false statements to the U.S. in connection with the submission of false cost reports to Medicare. The fine amount is $22.6 million; and,

Western District of Texas (El Paso) -- Columbia Homecare Group will plead to a conspiracy to pay kickbacks and other monetary benefits to doctors in violation of the Medicare Anti-kickback Statute. The criminal fine is $30.1 million.

The case was extensively dicussed in Money-Driven Medicine by Maggie Mahar, who suggested that the business culture that Scott created lead to these crimes:
Scott was obsessed not just with winning, but with money

He bullied his subordinates. 'My father owned and operated a millinery factory in the garment district and [even in that tough garmento environment] I never witnessed such an extent of demeaning, debasing, and devaluing behavior as I personally experienced at Columbia,' Mark E. Singer, administrative director for medicine at Michael Reese Hospital in Chicago told The New York Times.

Internal records showed that at Columbia/ HCA, just as at many other for-profits, executive salaries hinged not on such criteria as reducing infections or lowering death rates, but on meeting financial targets like 'growth in admissions and surgery cases.'

Scott's detractors claimed that his cost cutting threatened patient care and safety: 'Gloves come in only one size and rip easily,' complained hospital workers in Florida. In California, nurses protested 'filty conditions,' and being 'stretched to the limit'....

The Sun-Sentinel article included allegations that Scott actually knew about the crimes to which Columbia/ HCA subsidiaries pleaded guilty:
Alderson thinks Scott had to know.

The hospitals kept two sets of books: One showed the reimbursements actually submitted to Medicare and the other, marked confidential, detailed those charges that would likely be rejected if caught by federal auditors.

The company kept funds in reserve to repay the government for those claims and once the timeframe for an audit had passed, the reserves would be reclassified as revenue, Alderson said.

'They had $1 billion in play in these reserves,' said Alderson, who now lives in La Quinta, Calif., and speaks to college students and Rotary clubs about business ethics. 'Anywhere from 25 to 33 percent of their bottom line was these reserves, so you bet he knew about it.''

Scott was never charged with a crime. Instead, he "left Columbia/HCA with $10 million in severance and stock valued at $300 million." Now, he "lives in Naples in a $9 million house on the Gulf of Mexico."

But,
Joe Ford, the FBI agent who led the Columbia/HCA investigation and then took on corporate fraud at Enron, retired from the bureau and lives near San Francisco. He declined to comment for this story article but was quoted in a 2008 book by Schilling as saying that his biggest regret in the Columbia/HCA case was not charging corporate executives.

'After Columbia/HCA, I realized people, individual corporate officers, had to be held ccountable for the actions of their companies,' Ford said in Schilling's book, 'Undercover: How I Went from Company Man to FBI Spy � and Exposed the Worst Healthcare Fraud in U.S. History.'

'Instead of just giving us [the government] money, people need to go to jail,' Ford said in the book. 'I learn from my mistakes, and this was my first big one.'

Of course, we have noted a parade of legal settlements involving and guilty pleas and criminal convictions by  health care organizations, (or often just subsidiaries conveniently available to take the rap).  As we have noted, resulting fines may be just be treated as costs of doing business by health care leaders.  Almost never have the people who authorized, directed, or implemented wrong-doing almost never suffer negative consequences.

Instead, they may just continue to haunt health care and society at large.

Mr Scott's campaign web-site noted "mistakes were certainly made at Columbia/ HCA. As CEO I accept responsibility for what happened on my watch."

If only....

To conclude, as I have repeated seemingly infinitum, we will not deter unethical behavior by health care organizations until the people who authorize, direct or implement bad behavior fear some meaningfully negative consequences. Real health care reform needs to make health care leaders accountable, and especially accountable for the bad behavior that helped make them rich.

ADDENDUM (27 May, 2010) - see comments by Maggie Mahar on the Health Beat Blog.

Food Allergy Assumptions

Anaphylaxis Australian says, "assumptions or inactions often lead to avoidable reactions". This is in response to a discussion about dining with food allergy. While those of us who live this every day know that we should never make assumptions about what is in the food we serve to our food allergic loved one,there are several points that bear repeating:

Check all labels every time.
Always carry emergency medication.
Never assume that a food is safe.
Specifically talk to wait staff and/or the chef about food allergy when dining out. Consider a chef card. Leave if "it doesn't feel right".
Know that anything could contain a hidden ingredient- peanut butter in chili, dairy in non-dairy whipped topping. Do your research.

Here's the article that sparked this list. Do you have anything to add?

Tuesday, May 25, 2010

Medical transcription outsourcing: The right solution for healthcare facilities to cope with expansion plans

In today’s world change is the one thing, which is constant. Change has never been more relevant than when it comes to healthcare. A healthcare facility has to cope up with the latest developments in healthcare, all the while stretching their budgets to the limit. The latest equipment, the latest techniques, adding on new specialties to the existing practice, all this can put a strain on limited resources.

As the scope of operations of a healthcare facility keep expanding their back office requirements like medical transcription and medical billing needs also expand accordingly. As this happens the first reaction of the healthcare facility is to add on more staff to cope up with increasing medical transcription needs or alternately outsource the overflow of transcription requirements to independent contractors or to a medical transcription service provider or a combination of all three.

This move provides a solution albeit temporarily. But as time passes there could be serious discrepancies in terms of the following:

Quality of reports: The accuracy level or the quality of the finished transcripts depends totally on the quality of people working on it. Use of varied sources to cope with medical transcription needs can dilute the quality control. This could have an impact on the quality of healthcare.

Turnaround time: Having varied turnaround time would mean that all the data needed to make an informed decision would not be available to the healthcare professional at the right time, which can affect the timeliness of the care imparted.

Cost per line of transcription: Having transcription done by various sources would mean that the cost per line of transcription would increase.

Systems/media used for transcription: The technology used for transcribing would be diverse given the different sources, all these would mean additional costs for integration with the healthcare facility systems.

Serious issues with HIPAA and HITECH compliance: HIPAA/HITECH compliance would be difficult to monitor given the numerous entities involved in the process.

Delays in processing for the accounts receivable cycle: Medical transcription is the first stage of the accounts receivable cycle; delay in medical transcription would mean delays in the rest of the reimbursement process.

Time spent coordinating various sources of medical transcription increases: Report distribution and signing of finished transcripts would be delayed due to the various sources of medical transcription work.

Manpower dealing with medical transcription providers would increase: The healthcare facility would have to appoint extra people to coordinate the varied sources of transcription to ensure a smooth workflow.

All these factors can have a serious impact on both the quality of healthcare and the bottom-line of the healthcare facility.


What is the most economical and efficient solution to cope with expanding needs of a healthcare facility?

Outsourcing medical transcription needs to TransDyne would provide a one-stop solution for all the medical transcription needs of a healthcare facility no matter what their expansion plans.

How does TransDyne provide a one-stop solution to the medical transcription needs of a healthcare facility?

TransDyne provides superior solutions for medical transcription needs by having:

Right people: TransDyne has a large team of well-trained medical transcriptionists in place. TransDyne believes that training should be slanted in such a way as to provide maximum expertise in minimum time. That is why medical transcriptionists in TransDyne have been trained in one or two areas of specialty making them domain experts. This means that the team at TransDyne can cope with the varying volumes of transcription without affecting the accuracy or the turnaround time.

Right process: TransDyne has the right processes in place that ensure not only quality and turnaround time but also HIPAA and HITECH compliance. All the transcription work is executed in-house and not through sub contractors, this ensures better control over quality and safety of information. Quality of final transcripts is ensured through a four level check involving medical transcriptionist, proofreader, unit-in-charge and the quality assurance team.

Right technology: TransDyne uses the latest technology to ensure:

1.Easy upload, by allowing the healthcare professionals to retain familiar and flexible modes of dictation

2.Safety during transmission through the use of encryption, firewalls and password protected access.

3.Easy download of file to enable distribution of finished transcripts.

4.A system which ensures ease of tracking dictations, finished transcripts and archiving facilities that can be customized to the healthcare facility’s needs


By having the right people, right processes and right technology in place TransDyne offers:

  • Medical transcription at the right price – at least 40% lower than current costs incurred by the healthcare facility.
  • Accuracy of above 99%
  • Turnaround time of 24 hours with an option of 4-12 hours for STAT reports.
  • HIPAA and HITECH compliant medical transcription
  • Fair billing methods to ensure that cost per line of transcription is understood clearly.
  • Systems that integrate with that of the healthcare facility without any additional investment on their part.
To avail outsourced medical transcription services from TransDyne, click here.

Genzyme Settles

In late 2009, we posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Cerezyme whose cost to patients approximated $160,000 a year.  We thought then that for a drug costing that much, the company ought to have figured out a conservative process to provide pure and unadulterated product.  In a later post we also why a company that could afford to make its CEO very rich could not afford to adequately maintain its manufacturing facilities.

Now Genzyme has reached a settlement with the US Food and Drug Administration (FDA) on the matter.  As reported by the Boston Globe,
Genzyme Corp will remain under federal oversight for the next seven to eight years as it works to fix quality-control problems that have bedeviled its Allston Landing plant for 15 months.

The timetable was spelled out in a consent decree struck between Genzyme and the Food and Drug Administration.

Under its terms, Genzyme will pay a previously disclosed $175 million federal fine, the first in its 29-year history. The agreement, filed with the US District Court in Boston yesterday, is subject to court approval.

Although the company said last month that it expected to pay the $175 million fine, other terms of the consent decree were not known until yesterday. Among them, Genzyme agreed to move fill-finishing work for its domestic drug shipments out of the Allston site by November. The transfer of fill-finishing for overseas shipments will take place by Aug. 31, 2011.

Fill finishing is the process of pouring drugs into vials for shipments to hospitals and clinics, where they are administered to patients.

Late last year, inspectors found bits of steel, rubber, and fiber in some drugs during the fill-finishing process in Allston. The work will be moved to a Genzyme operation in Waterford, Ireland, and to subcontractors such as Hospira Inc., subject to approval by federal regulators.

The firm faces additional fines if it fails to meet FDA deadlines

In all, the Cambridge biotechnology giant will spend two to three years in remediation under the consent decree, and another five years under oversight by a third-party contractor, the Quantic Group, a Livingston, N.J., consulting firm focused on boosting manufacturing quality and safety.

Quantic will craft a remediation plan with Genzyme, and the company could be fined $15,000 a day for missing milestones.

So now Genzyme is marching in our parade of settlements.  While this settlement is of charges related to very fundamental violations, failure to manufacture pure and unadulterated drugs, in one important way its provisions seem similar to many other such settlements we have now seen.  The settlement fines the company as a whole, but results in no penalties for any individuals. 

As we have noted before, fines, even fines larger than this one, can be regarded just as a cost of doing business (especially when the business is very lucrative.  The company's 2010 proxy statement noted that even in 2009, when production was affected by the plant closure, "sales of Cerezyme were $793 million, compared with $1.2 billion in 2008. Sales of Fabrazyme were $431 million compared with $494 million in the previous year. So the company was fined $175 million for production problems with two drugs that brought in over $1.2 billion in revenue in 2009.) 

Furthermore, the fine's impact may be diffused over the whole company, and ultimately comes out of the pockets of stockholders, employees, and customers alike.  It provides no negative incentives for those who authorized, directed, or implemented the behavior in question.  So it is not clear that settlements like this deter future wrong-doing.

Additionally, as we noted in the earlier post, the current CEO of Genzyme has gotten quite rich by virtue of his position.  While the 2010 Genzyme proxy statement indicates his compensation was affected by the financial impact of the production slowdown, even so he continued to get richer, albeit at a slightly slower pace than he did before.  That statement indicates that in 2009, CEO Henri Termeer's total compensation was a mere $9,507,403, down from $12,699,301 the previous year.  The main difference was that his non-equity incentive plan compensation dropped from $1,962,725 to 0.  While a $3 million plus salary decrement seems sizable, it is hard to conceive of an executive who makes nearly $10 million a year as suffering major financial consequences from the current debacle. 

As I have said before, endlessly, we will not deter unethical behavior by health care organizations until the people who authorize, direct or implement bad behavior fear some meaningfully negative consequences. Real health care reform needs to make health care leaders accountable, and especially accountable for the bad behavior that helped make them rich.

Gas Fueled Power Systems

This Spring, many houses in Massachusetts suffered flooding due to failed sump pumps. This motivated me to replace our existing sump pump and install a back system.

When I think about home disaster recovery in general, an electrical power is a single point of failure. When does power fail - during a storm, when you need heat, water pumping, and humidity control.

The likelihood that gas (natural gas/liquid propane) will fail at the same time as electrical is very remote, so natural gas powered electrical generators seem like a reasonable choice for creating home electrical redundancy.

Home Depot sells the kind of unit that is needed.

Yes, it must be professionally installed, but if you live in an area with frequent storms and power outages, natural gas fueled standby and backup power systems make sense.

Speaking of "natural" gas, the New York Times recently published an article about using methane from cow manure to power data centers. Since many new data centers are being built near inexpensive hydroelectric power in rural areas where manure is prevalent, this may be a reasonable alternative energy source.

Here's the opinion of our power experts on using manure to power infrastructure:

*Similar in some ways to a co-generation plant but using farm waste instead of natural gas.

*Natural gas in the streets only has a small amount of methane, because methane is a low pressure gas.

*High pressure gases need to be used to generate significant amounts of power via gas turbines & steam.

*Methane being a low pressure gas does not burn as hot and cannot handle sudden increases in loads.

*Typically farmers burn the cow patties directly to produce heating for their homes.

*The NY Times article did not describe the step needed to store methane in a high pressure form that can support power generation.

* Bird manure has a higher energy content and has been used more successfully.

A few thoughts specific to data centers:

*Natural gas back-up generators typically do not have on-site storage since stored natural gas can be highly explosive

*Storage of liquified gas is allowed on ground level floors, but it is stored at 0-degrees Kelvin and a large containment area needs to be established because if a leak were to occur, everything it comes in contact with would be frozen instantly and become brittle.

*The diesel generators at datacenters typically have 48-72hrs. of fuel available on site to run stand alone.

*Natural gas turbines are twice as expensive as diesel engines.

*Reliability and redundancy are always important, therefore the methane power plant would need a utility back-up line to supplement the methane plant during sudden increases of electrical load and back-up the plant in the event of failure or maintenance downtime. The utility line would have to be sized to feed the entire datacenter.

*When a gas leak is detected in the street the utility provider will shutdown the entire line affecting all users until the leak is found and repaired. Therefore, redundant pipes from different sources would be needed to maintain uptime of the gas feed.

Thus, manure is not an easy solution to the problem of growing data center power needs. However, as energy costs rise and carbon footprint becomes more important, it's worth keeping in mind.

The best quote from the article - �Information technology and manure have a symbiotic relationship.�

Monday, May 24, 2010

The Stewards of an Elite University, or a "Politburo" of "Shadow Bankers?"

We have postulated that one of the key reasons US health care has become so dysfunctional is that the leaders of some of the most august health care institutions have strayed from, if not totally abandoned their organizations' fundamental missions.  There are many possible reasons for this phenomenon, but one is that the ultimate stewards of not-for-profit health care organizations, their boards of directors or trustees, have become uninterested in the mission, or impotent to uphold it.  So, we have tried to figure out what has happened to these boards that has lead to this sorry state.

Dartmouth College: the Packing of the Board of Trustees

One example we have come frequently discussed (beginning here) is that of Dartmouth College, despite its name, really a university, and one of the elite American universities which includes a well-regarded medical school.   For a long time, Dartmouth had one of the more accountable and representative systems of governance found in US universities.  Recently, however, this accountability and transparency was challenged by some of the College's own leaders. 

Most boards of trustees are self-elected.  When an old member leaves, the new members elect his or her successor.  Dartmouth alumni, however can elect eight members of the board of trustees. Until recently, eight others were "charter trustees," who were individually chosen by the other charter trustees, and two were ex-officio. Although the College's Association of Alumni traditionally nominated alumni to run for trustee positions, candidates could be nominated by petition, and starting in 2004, four such petition candidates were elected.

As described by FIRE, the Foundation for Integrity and Responsibility in Medicine, this more open process fostered change in how the university was lead, and seemed to foster renewed attention to the institution's mission:
These trustees spoke out when they perceived their alma mater as not living up to its mission, and Dartmouth students benefited. In May 2005, the college repealed its speech code, and it immediately moved from FIRE's 'red-light' rating and became a 'green-light' institution.

As might be expected, the reigning leadership was not pleased.

Some campus officials viewed the propensity of petition candidates to voice their opinions on illiberal policies as detrimental to the school's image. The Wall Street Journal profiled T.J. Rodgers, a petition-nominated trustee, who explained the criticisms leveled at the 'divisive dissidents.'

'If 'divisive' means there are issues and we debate the issues and move forward according to a consensus, then divisive equals democracy, and democracy is good. The alternative, which I fear is what the administration and [Board of Trustees Chairman] Ed Haldeman are after right now, is a politburo-one-party rule.'

In 2007, in apparent response to the "divisiveness" of the petition trustees, the Charter Trustees proposed increasing their own numbers. Chairman Ed Haldeman's rationale for this, as we discussed here, was to ensure that the board "has the broad range of backgrounds, skills, expertise, and fundraising capabilities needed," and that the board members would possess "even more diverse backgrounds."

Charter Trustees or "Shadow Bankers"?

Yet when we examined the backgrounds of the current charter trustees, we found that they exhibited little diversity. Remarkably, three-quarters (6/8) were in leaders of the finance sector. The board chairman, Ed Haldeman, was then the leader of Putnam Funds.  Now, he is the CEO of "Freddie Mac."  In 2007, the significance of this kind of lack of diversity were not clear.  However, it did seem strange that those accused of seeking to form a "politburo" came from the Wall Street, the street that the left once loved to hate.

However, by late 2008, the world economy descended into an unprecedented financial collapse. Many concluded that the global economic collapse was caused by arrogance, greed, and corruption within the financial sector. This suggested that leadership of academia, and academic medicine in particular, by leaders of the finance sector might not, in retrospect, have been a such a good idea. When we reexamined the composition of the now enlarged cohort of Charter Trustees, however, we found nine of 13 "charter" trustees were leaders in finance, now including three in asset management, two in private equity, one in the field formerly known as investment banking, one in venture capital, one in mutual funds, and one in strategic consulting and investment. Of the remaining four, one was the CEO of a large diversified corporation that has a major finance subsidiary. The remaining three were two physicians and a pharmaceutical corporate CEO.

Given the ongoing financial chaos at the time, we again suggested that a board dominated by business leaders in the finance sector might not be a good idea. Last week, a report came out suggesting why we were right.

Charter Trustees as Dartmouth's Own "Shadow Bankers"

"Educational Endowments and the Financial Crisis: Social Costs and Systemic Risks in the Shadow Banking System," published by the Center for Social Philanthropy, Tellus Institute, focused on how prominent educational institutions, including Dartmouth College, came to invest much of their endowments in risky, illiquid "alternative" investments, the sort provided by the "shadow banking system." The report noted that this change lead to greater financial risks, leading to recent losses and consequent sharp cutbacks in spending, programs, and employment at the affected institutions. In particular, however, it focused on leadership and governance problems at the institutions that lead to this state of affairs.
Although the emergence of the high-risk Endowment Model of Investing has taken place against the backdrop of powerful forces of financial globalization and the influence of Modern Portfolio Theory, its consolidation and influence today at colleges and universities depend vitally on college leaders: senior administrators, trustees, and investment managers, especially the increasingly prominent role of chief investment officer, or CIO. The financial crisis has in many ways been a crisis of leadership. The precipitous declines endowments have suffered during the credit crisis need to be understood as the logical outcome of the Endowment Model�s high risk strategies, but behind the model stand those who are ultimately responsible for its execution: whether as professional money managers, investment officers, affiliated investment management companies, outside managers, or investment consultants, or as the fiduciaries sitting on governing boards and investment committees.

At Dartmouth, in particular, the report focused on conflicts of interest among the board of trustees:
When it comes to weakened endowment oversight, the most glaring problem arises from trustees from the finance industry whose firms provide investment management services. One of the most disconcerting cases in this respect is that of Dartmouth College, where the sudden departure of CIO David Russ in 2009 created a leadership vacuum over endowment management. The college�s investment committee chair and trustee Stephen Mandel has played the CIO role on a voluntary, part-time basis since last summer and will continue to do so until he becomes chair of the board of trustees later this year. At the same time, Mandel�s firm, Lone Pine Capital LLC, a well known hedge-fund complex he founded in 1997, has also managed an investment mandate from the college�s endowment valued originally at $10 million. Although the college has a conflict-of interest policy and is required to disclose such 'pecuniary benefit transactions' with the state of New Hampshire, it would seem difficult for fellow trustees to provide proper oversight of investments managed by a fellow trustee serving as the de-facto CIO. Additionally, if Mandel recuses himself from committee or board deliberations related to his firm, then the investment committee must function without its chair.

However, the problem is magnified because Mandel is only one of more than half a dozen Dartmouth trustees whose firms manage multimillion-dollar investments for the endowment, according to the college�s filings with Charitable Trusts Unit of the New Hampshire Department of Justice. Leon Black�s firm Apollo Management has reportedly managed at least $40 million in Dartmouth investments. Russell Carson�s private equity firm[Welsh, Carson, Anderson and Stowe] has reportedly received at least $45 million in commitments of capital from Dartmouth. William Helman, IV�s venture capital firm Greylock Partners, has reportedly received $10 million investment mandates from the college, while R. Bradford Evans� firm Morgan Stanley has done multiple transactions
with the college, varying from investments in international real estate and hedge funds to bond issuances, all at undisclosed levels. P. Andrew McLane [T A Associates] and Jonathan Newcomb [Leeds Weld and Co] have also had reported interests in college investments at undisclosed levels. For an endowment of its size� Dartmouth�s endowment fell to less than $3 billion in fiscal year 2009�the deep dependence on trustees� own businesses for endowment management seems disproportionate.

Thus, one half of the membership of Dartmouth's Charter Trustees were also being paid by Dartmouth to manage its endowment investments.  However, as the Tellus Institute report noted,
Leading experts on nonprofit board governance, such as Richard Chait at Harvard University, stress that colleges should simply not do business with the companies of their board members, in order to avoid inevitable distractions and the sense of divided loyalties that arise, to say nothing of appearances of self-dealing and personal enrichment

Another "Missing Link": Board Members Doing Business with the Organizations They are Supposed to Steward

We have frequently discussed the web of conflicts of interest that now permeates health care.  Most of the conflicts we have discussed up to now involve physicians or academicians who have financial ties to pharmaceutical, biotechnology, and device companies.  Health care organizational leaders also do business  with the organizations they lead have not until recently been a topic of discussion, mainly because such conflicts of interest have rarely been disclosed.

It looks like this is going to change.  The US Internal Revenue Service sought disclosure of such conflicts of interest affecting hired executives and boards of trustees of not-for-profit organizations beginning in 2009.  These disclosures, reported on IRS form 990, are just beginning to be made public.  We just posted about members of the board of directors of a large academic health care system who also lead or owned companies that did substantial business with the system.  Now we see that a substantial portion of the board of trustees of Dartmouth lead financial firms that managed a major portion of the College's endowment, perhaps to the overall detriment of the endowment's performance.  No wonder the Charter Trustees got nervous about petition trustees poking about their business.

 As summarized by BoardSource, there are three traditional duties of members of boards of trustees of not-for-profit organizations:
Duty of Care

The duty of care describes the level of competence that is expected of a board member, and is commonly expressed as the duty of "care that an ordinarily prudent person would exercise in a like position and under similar circumstances." This means that a board member owes the duty to exercise reasonable care when he or she makes a decision as a steward of the organization.

Duty of Loyalty

The duty of loyalty is a standard of faithfulness; a board member must give undivided allegiance when making decisions affecting the organization. This means that a board member can never use information obtained as a member for personal gain, but must act in the best interests of the organization.

Duty of Obedience

The duty of obedience requires board members to be faithful to the organization's mission. They are not permitted to act in a way that is inconsistent with the central goals of the organization. A basis for this rule lies in the public's trust that the organization will manage donated funds to fulfill the organization's mission.

Letting a board member's firm manage millions of dollars worth of the institution's endowment portfolio seems an obvious violation of the duty of loyalty. (Letting a board member's legal firm handle the institution's legal issues, or having a board member's advertising firm do its marketing, as described in our earlier post, also seem to be obvious violations of this duty.) A board member who sees nothing wrong with doing business with the organization he or she is supposed to steward would likely see nothing wrong in allowing the organization's mission to become a casualty of the means used to protect that business relationship.

I suspect we are soon to see many more examples of hired executives and board members of revered not-for-profit organizations who have been doing business on the side with the organizations of which they are supposed to be leaders or stewards.  These sorts of conflicts of interest may be another "missing link" explaining why the leadership and governance of health care organizations has gone so far astray. 

As disclosure continues, maybe enough outrage will ensue so that improved leadership and governance will become possible. 

Blood Test For Risk of Food Allergy

A simple blood test is able to predict whether newborns are at risk for developing allergies later in life. Researchers at the University of Adelaide in Australia have determined that a specific protein separates those infants who are susceptible to developing allergies from those who are not.

It's all in the protein kinase C zeta, dah...ling...

This holds great benefit for those families who already have one or more members dealing with food allergy. Creating an allergy action plan for at risk babies is much easier than playing catch-up after trial and error testing finally points to allergy in a child. This test takes out much of the guesswork.

There is a great deal of food allergy research in Australia as 40%, yes four zero, of Australian children suffer from some type of allergic disease.

Check out the full story.

Digital Signatures with SAFE-BioPharma

In the recent TISH meeting I attended, one of the discussants emphasized authentication/securing the endpoints/identity management as one of the great enablers of healthcare information exchange.

SAFE-BioPharma is a multi-stakeholder effort that uses digital certificates with private keys held on a smartcard or a USB device to provide electronic signatures which the FDA has determined meet 21 CFR Part 11 requirements, and also to authenticate securely among the stakeholders and Federal government agencies. The effort uses public key infrastructure and enables all of the stakeholders to have a common trust relationship with Federal agencies using the Federal government�s own federated security mechanisms.

As we think about strong authentication methods - biometrics, hard tokens, and smart cards, the SAFE-BioPharma approach is another option to consider.

How does it work?

SAFE-BioPharma member companies are using the SAFE-BioPharma standard in ways that achieve numerous goals including streamlining processes, protecting intellectual property and reducing costs. The standard is a convenient way to apply legally binding (and regulatory compliant) digital signatures to electronic documents. The identity of the signer is clearly verified and the integrity of each digitally signed document is cryptographically guaranteed. SAFE-BioPharma digital signatures are being used to sign electronic laboratory notebooks, electronic regulatory submissions, contracts and a wide variety of forms. Member companies also use the SAFE-BioPharma standard for a variety of identity management functions including employee access, external partner authentication, etc.

For details on the companies involved, the actual systems in production and the business processes used to implement SAFE-BioPharma in production, see this summary.

SAFE is achieving federated identity management using digital certificates on inexpensive smartcards or USB devices. Definitely worth adding to our strong authentication armamentarium.

Related Posts Plugin for WordPress, Blogger...